An evidence-based approach in the treatment of Huntington's disease.
about
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanismsThe P42 peptide and Peptide-based therapies for Huntington's diseasePluripotent stem cells models for Huntington's disease: prospects and challengesThe Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets.Stem cells for cell replacement therapy: a therapeutic strategy for HD?Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's diseaseDopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.Nanoparticles based stem cell tracking in regenerative medicine.The role of dopamine in Huntington's disease.Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?Pridopidine for the treatment of Huntington's disease.Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.RNAi joins the "Singles Club"CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's DiseaseRevisiting the neuropsychiatry of Huntington's disease.Treatment options for chorea.Caregiving Youth Knowledge and Perceptions of Parental End-of-Life Wishes in Huntington's Disease.Huntington disease
P2860
Q21131050-1F6574F6-1CA6-4AE5-8E52-4F9C766AF989Q26764930-886F2E6F-BDC5-466C-8338-747D9EE8CC96Q26860151-9EAED184-D893-4348-9F67-B70A9524D854Q34921682-79D09856-BB9C-481C-B798-289733078EAAQ35049600-D078DCF5-12F7-4833-BD87-9A6B1981B0A9Q35250495-F36BDEE9-C153-453B-A5C7-40CB01FB1950Q37267145-BBC709A6-7547-4852-9486-43CC7641B656Q38121068-3470DB3E-4F6A-4F38-996A-CC83A41FE148Q38129058-0F378F3C-BFFC-40F4-80EE-12791932D0A5Q38223504-73707344-697F-451A-916A-887DBB194489Q38244078-073CBC25-4C0E-4D54-A5DA-3504F5066471Q38735562-96DD9502-2110-410D-AA1E-383F53009E44Q40277912-E14BA892-AE51-42CC-967E-63DE4829B6E8Q41136404-F9135E08-9850-4E6B-823C-66BAA1E4242AQ42289973-0057C5B3-85B4-48D9-BB4C-A95ED320F484Q45305909-1D9E2329-4EA1-4C51-AAFE-F4B8275535D1Q47977953-3EB929D6-1CC5-45A7-B10B-85CDBCC8F635Q50110610-42E4D6B6-36A5-4D78-9B79-B750EE6EE92DQ56083219-0CAAFEA2-F738-46B9-A3B6-8021C055CDF9
P2860
An evidence-based approach in the treatment of Huntington's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An evidence-based approach in the treatment of Huntington's disease.
@en
An evidence-based approach in the treatment of Huntington's disease.
@nl
type
label
An evidence-based approach in the treatment of Huntington's disease.
@en
An evidence-based approach in the treatment of Huntington's disease.
@nl
prefLabel
An evidence-based approach in the treatment of Huntington's disease.
@en
An evidence-based approach in the treatment of Huntington's disease.
@nl
P1476
An evidence-based approach in the treatment of Huntington's disease
@en
P2093
J J Ferreira
T A Mestre
P304
P356
10.1016/J.PARKRELDIS.2011.10.021
P577
2011-12-16T00:00:00Z